Does Pathologic Complete Response Predict For Outcome Inbrca Mutation Carriers With Triple-Negative Breast Cancer?

Shani Paluch-Shimon, Eitan Friedman,Raanan Berger,Moshe Zvi Papa,Maya Dadiani,Neil Friedman,Moshe Shabtai,Douglas Zippel,Mordechai Gutman,Talia Golan,Raphael Catane,Ady Yosepovich, Tami Mekel Modiano,Bella Kaufman

JOURNAL OF CLINICAL ONCOLOGY（2014）

引用 7|浏览19

暂无评分

摘要

1023 Background: Pathological complete response (pCR) has been demonstrated to serve as a surrogate for outcome in patients receiving neo-adjuvant systemic therapy (NAT) for triple negative (TN) br...

查看译文

关键词

brca mutation carriers,breast cancer,pathologic complete response,triple-negative

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要